The deal, which will see Labcorp run 12 patient service centers, is part of the company’s ongoing efforts to expand through ...

At the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in ...

Get the latest Metropolis Healthcare share price today on NSE & BSE. Explore Metropolis Healthcare stock analysis, financial performance, market capitalization, dividend history, and future outlook ...

Thoracic aortic dissection is often approached as an acute and localised event, and pathological examination has ...

Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

New analyses show DLB patients with lower plasma pTau181 levels - indicating an earlier stage of disease and absence of ...

Patients with learning disabilities and needle phobia are benefiting from a painless new form of blood sampling pioneered by University Hospitals of Morecambe Bay NHS Foundation Trust.

In its third phase, the Diagnostics Accelerator will support the development of multi-marker panels leveraging digital and AI tools that can accelerate precision treatments.

AI-enabled platform auto-categorizes HER2 cases during scanning, allowing pathologists to review pre-analyzed results ...

Predictive cancer diagnostics company Rhythm Biosciences has activated its first commercial blood collection network in major ...